CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1

CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1

Abstract Background Acute myeloid leukemia (AML) is a myeloid neoplasm accounts for 7.6% of hematopoietic malignancies. AML is a complex disease, and understanding its pathophysiology is contributing to the improvement in the treatment and prognosis of AML. In this study, we assessed the expression...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: You Jiang, Shui-Yan Wu, Yan-Ling Chen, Zi-Mu Zhang, Yan-Fang Tao, Yi Xie, Xin-Mei Liao, Xiao-Lu Li, Gen Li, Di Wu, Hai-Rong Wang, Ran Zuo, Hai-Bo Cao, Jing-Jing Pan, Juan-Juan Yu, Si-Qi Jia, Zheng Zhang, Xin-Ran Chu, Yong-Ping Zhang, Chen-xi Feng, Jian-Wei Wang, Shao-Yan Hu, Zhi-Heng Li, Jian Pan, Fang Fang, Jun Lu
Format: article
Langue:EN
Publié: BMC 2021
Sujets:
CEBPG
EIF4EBP1
Acute myeloid leukemia
Proliferation
Apoptosis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Cytology
QH573-671
Accès en ligne:https://doaj.org/article/b51083088f36478e821450eab2fc3408
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/b51083088f36478e821450eab2fc3408

Documents similaires